SeaStar Medical Holding (ICU) Non-Current Debt (2022 - 2024)
SeaStar Medical Holding's (ICU) quarterly Non-Current Debt came in at $2.6 million in Q1 2024, down 55.35% YoY from $5.7 million in Q2 2023, and down 38.09% on a QoQ basis from $4.1 million in Q4 2023.
SeaStar Medical Holding (ICU) Non-Current Debt (2022 - 2024) Analysis & Trends
SeaStar Medical Holding (ICU) has 3 years of Non-Current Debt data on file, last reported at $2.6 million in Q1 2024.
- Quarterly Non-Current Debt fell 55.35% year-over-year to $2.6 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $2.6 million (down 55.35% YoY) and the FY2023 annual result came in at $4.1 million, down 45.86% from the prior year.
- Non-Current Debt declined to $2.6 million in Q1 2024, from $4.1 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $7.7 million in Q4 2022 to a low of $2.6 million in Q1 2024.
- A 3-year average of $5.2 million and a median of $5.7 million in 2023 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2023 — Non-Current Debt slumped 45.86% — and 2024, when it slumped 55.35%.
- Tracing ICU's Non-Current Debt over 3 years: stood at $7.7 million in 2022, then tumbled by 45.86% to $4.1 million in 2023, then tumbled by 38.09% to $2.6 million in 2024.
- The last three Non-Current Debt figures came in at $2.6 million (Q1 2024), $4.1 million (Q4 2023), and $5.7 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 8.96 Bn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 4.14 Mn |
| Sep 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 5.75 Mn |
| Dec 31, 2022 | 7.65 Mn |